Food and dietary supplement-drug interactions
Journal for the Integrated Study of Dietary Habits · 2026 · 37 (2) · 75-84
DOI: 10.2740/jisdh.37.2_75 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for the Integrated Study of Dietary Habits, 2026. Verfasst von Katsuyoshi Sunaga. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
The increasing use of health foods and dietary supplements has expanded opportunities for concomitant use with pharmaceuticals, making food-drug interactions an important issue affecting both treatment efficacy and patient safety. Such interactions are broadly classified into pharmacokinetic and pharmacodynamic interactions. Pharmacokinetic interactions occur when food components alter the absorption, distribution, metabolism, or excretion (ADME) of drugs. In the absorption phase, dietary fiber and mineral supplements may reduce drug absorption through adsorption or chelation, whereas high-fat meals can enhance the absorption of lipophilic drugs. Food constituents may also affect transporters such as organic anion transporting polypeptides (OATPs) and P-glycoprotein (P-gp), as well as intestinal cytochrome P450 3A4 (CYP3A4). Grapefruit juice is a representative example that increases systemic drug exposure through inhibition of intestinal CYP3A4. In the metabolism phase, St. John’s wort induces CYP3A4 and P-gp, whereas cannabidiol (CBD) has been reported to inhibit several CYP isoforms, potentially altering drug disposition. Nutritional status, plasma protein binding, renal function, urinary pH, and intestinal microbiota may further influence drug distribution and elimination. Pharmacodynamic interactions occur when food constituents and drugs exert additive, synergistic, or antagonistic effects on the same physiological systems. Typical examples include antagonism between warfarin and vitamin K-rich foods, increased bleeding risk associated with antithrombotic agents and certain supplements, and excessive pharmacological effects resulting from concomitant use of functional foods and medications with similar mechanisms of action. Because health foods and dietary supplements vary substantially in composition and quality, assessment of their interaction potential requires careful evaluation of products, dosage, and patient characteristics. This review provides a systematic overview of interactions between health foods, dietary supplements, and pharmaceuticals, with particular emphasis on ADME-related mechanisms and clinically important pharmacodynamic interactions.
Zitieren
APA
Sunaga, K. (2026). Food and dietary supplement-drug interactions. Journal for the Integrated Study of Dietary Habits, 37(2), 75-84. https://doi.org/10.2740/jisdh.37.2_75
Vancouver
Sunaga K. Food and dietary supplement-drug interactions. Journal for the Integrated Study of Dietary Habits. 2026;37(2):75-84. doi:10.2740/jisdh.37.2_75
BibTeX
@article{Sunaga2026,
author = {Sunaga, Katsuyoshi},
title = {Food and dietary supplement-drug interactions},
journal = {Journal for the Integrated Study of Dietary Habits},
year = {2026},
volume = {37},
number = {2},
pages = {75--84},
doi = {10.2740/jisdh.37.2_75}
}
EUVIMED